249 related articles for article (PubMed ID: 29888878)
21. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
[TBL] [Abstract][Full Text] [Related]
24. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
[TBL] [Abstract][Full Text] [Related]
25. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
Ferguson SW; Nguyen J
J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
[TBL] [Abstract][Full Text] [Related]
26. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.
Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM
Adv Drug Deliv Rev; 2013 Mar; 65(3):348-56. PubMed ID: 22820525
[TBL] [Abstract][Full Text] [Related]
27. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
Batrakova EV; Kim MS
J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
[TBL] [Abstract][Full Text] [Related]
28. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
Yamashita T; Takahashi Y; Takakura Y
Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
[TBL] [Abstract][Full Text] [Related]
29. Development and regulation of exosome-based therapy products.
Batrakova EV; Kim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
[TBL] [Abstract][Full Text] [Related]
30. Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
Srivastava A; Filant J; Moxley KM; Sood A; McMeekin S; Ramesh R
Curr Gene Ther; 2015; 15(2):182-92. PubMed ID: 25537774
[TBL] [Abstract][Full Text] [Related]
31. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
32. Delivery of Small Interfering RNAs to Cells via Exosomes.
Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
[TBL] [Abstract][Full Text] [Related]
33. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.
Amiri A; Bagherifar R; Ansari Dezfouli E; Kiaie SH; Jafari R; Ramezani R
J Transl Med; 2022 Mar; 20(1):125. PubMed ID: 35287692
[TBL] [Abstract][Full Text] [Related]
34. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes.
Kim H; Yun N; Mun D; Kang JY; Lee SH; Park H; Park H; Joung B
Biochem Biophys Res Commun; 2018 May; 499(4):803-808. PubMed ID: 29621543
[TBL] [Abstract][Full Text] [Related]
35. Exosomes and their Application in Biomedical Field: Difficulties and Advantages.
Rezaie J; Ajezi S; Avci ÇB; Karimipour M; Geranmayeh MH; Nourazarian A; Sokullu E; Rezabakhsh A; Rahbarghazi R
Mol Neurobiol; 2018 Apr; 55(4):3372-3393. PubMed ID: 28497202
[TBL] [Abstract][Full Text] [Related]
36. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
Lin Y; Lu Y; Li X
J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
[TBL] [Abstract][Full Text] [Related]
37. Exosome mimetics: a novel class of drug delivery systems.
Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
[TBL] [Abstract][Full Text] [Related]
38. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
Srinivas L; S D; Kgk D; Malla RR
Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
[TBL] [Abstract][Full Text] [Related]
39. Exosomes as Tools to Suppress Primary Brain Tumor.
Katakowski M; Chopp M
Cell Mol Neurobiol; 2016 Apr; 36(3):343-52. PubMed ID: 26983831
[TBL] [Abstract][Full Text] [Related]
40. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]